119 related articles for article (PubMed ID: 15530662)
1. Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies.
Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):131-5. PubMed ID: 15530662
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.
Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):601-7. PubMed ID: 15541000
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
Brain Res Mol Brain Res; 2004 Mar; 122(1):1-9. PubMed ID: 14992810
[TBL] [Abstract][Full Text] [Related]
5. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
6. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
[TBL] [Abstract][Full Text] [Related]
7. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease.
Beyer K; Humbert J; Ferrer A; Lao JI; Carrato C; López D; Ferrer I; Ariza A
Neuroreport; 2006 Aug; 17(12):1327-30. PubMed ID: 16951579
[TBL] [Abstract][Full Text] [Related]
8. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
9. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.
Panegyres PK; Zafiris-Toufexis K; Kakulas BA
J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649
[TBL] [Abstract][Full Text] [Related]
10. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent differential regulation of genes encoding APP and alpha-synuclein in hippocampal synaptic plasticity.
Stéphan A; Davis S; Salin H; Dumas S; Mallet J; Laroche S
Hippocampus; 2002; 12(1):55-62. PubMed ID: 11918289
[TBL] [Abstract][Full Text] [Related]
12. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation.
Ledoux S; Rebai N; Dagenais A; Shaw IT; Nalbantoglu J; Sekaly RP; Cashman NR
J Immunol; 1993 Jun; 150(12):5566-75. PubMed ID: 8515076
[TBL] [Abstract][Full Text] [Related]
14. The Kunitz-protease inhibitor domain in amyloid precursor protein reduces cellular mitochondrial enzymes expression and function.
Chua LM; Lim ML; Wong BS
Biochem Biophys Res Commun; 2013 Aug; 437(4):642-7. PubMed ID: 23872114
[TBL] [Abstract][Full Text] [Related]
15. Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies.
Revuelta GJ; Rosso A; Lippa CF
Am J Alzheimers Dis Other Demen; 2008; 23(1):97-102. PubMed ID: 18276962
[TBL] [Abstract][Full Text] [Related]
16. Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study.
Vignini A; Morganti S; Salvolini E; Sartini D; Luzzi S; Fiorini R; Provinciali L; Di Primio R; Mazzanti L; Emanuelli M
Exp Gerontol; 2013 Dec; 48(12):1505-8. PubMed ID: 24400342
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-amyloid precursor protein gene is developmentally regulated in human muscle fibers in vivo and in vitro.
Sarkozi E; Askanas V; Johnson SA; McFerrin J; Engel WK
Exp Neurol; 1994 Jul; 128(1):27-33. PubMed ID: 8070521
[TBL] [Abstract][Full Text] [Related]
18. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
[TBL] [Abstract][Full Text] [Related]
20. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
